Skip to content
Screener

Vericel VCEL Q1 2025 earnings

Reported May 8, 2025 · Before market open

Revenue$52.6MMiss by $12.2M
EPS-$0.23Miss by $0.14
Revenue estimate$64.8M
EPS estimate-$0.09

Next report

Nov 5, 2026 (in a month)
Revenue estimate$78.0M
EPS estimate$0.02

Financials

Q1 2025

Income statement

See full
Revenue$52.6M+2.6%
Gross profit$36.3M+2.6%
Operating income-$12.8M-134%
Net income-$11.2M-191%
EPS (diluted)-$0.23-188%

Balance sheet

See full
Cash & equivalents$79.7M+12.7%
Total debt$99.6M+8.1%
Total equity$295.5M+26.3%
Total assets$424.6M+19.0%

Cash flow

See full
Operating cash flow$6.6M-8.4%
CapEx$14.2M+1.4%
Free cash flow-$7.6M-11.7%

Valuation & ratios

Valuation

as of 03/31/25
See full
Market cap$2.24B-11.1%
Enterprise value$2.26B-11.1%
P/E751.2×—
P/S9.4×-2.7×

Profitability

See full
Gross margin72.5%+3.0pp
Operating margin-1.2%—
Net margin1.2%—

Returns & leverage

See full
Return on equity1.1%—
Debt / equity0.3×-0.1×
Current ratio5×-0.2×

Segments

By product

See full
M A C I Implants and kits$46.3M+15.2%
MACI implants, kits, and instruments$31.8M+17.1%
Epicel$5.0M-53.5%
Biopsy kits$596.0K+5.5%

FAQ

When did Vericel report Q1 2025 earnings?
Vericel (VCEL) reported Q1 2025 earnings on May 8, 2025 before market open.
What were Vericel's Q1 2025 revenue and EPS?
Vericel reported revenue of $52.6M and eps of $-0.23 for Q1 2025.
Did Vericel beat estimates in Q1 2025?
Revenue missed the consensus estimate of $64.8M by $12.2M. EPS missed the consensus estimate of $-0.09 by $0.14.
How did Vericel's Q1 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 2.6% from $51.3M a year earlier and eps declined 187.5% from $-0.08.
Where can I find Vericel's Q1 2025 SEC filings?
You can read the 8-K earnings release (0001628280-25-023481) and the 10-Q periodic report (0001628280-25-023496) directly on SEC EDGAR. The filing index links above go to sec.gov.